title: [Marked improvement of "severe acute pancreatitis" with continuous administration of protease inhibitor: nafamostat mesilate (Futhan) via intraarterial infusion in a case].
authors.affiliation: Department of Internal Medicine, Hakodate Goryoukaku Hospital.
authors.forename: K
authors.initials: K
authors.lastname: Kawasaki
authors.forename: Y
authors.initials: Y
authors.lastname: Arimura
authors.forename: H
authors.initials: H
authors.lastname: Hirata
authors.forename: T
authors.initials: T
authors.lastname: Suzuki
authors.forename: Y
authors.initials: Y
authors.lastname: Kakumoto
authors.forename: H
authors.initials: H
authors.lastname: Kaneto
authors.forename: M
authors.initials: M
authors.lastname: Mihara
authors.forename: K
authors.initials: K
authors.lastname: Imai
mesh_terms: D000208:Acute Disease; D001550:Benzamidines; D006146:Guanidines / Q000008:administration & dosage*; D006801:Humans; D007261:Infusions, Intra-Arterial; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000188:drug therapy*; D011480:Protease Inhibitors / Q000008:administration & dosage*
chemical_list: D001550:Benzamidines; D006146:Guanidines; D011480:Protease Inhibitors; C032855:nafamostat